
As the desire for non-invasive body contouring increases in demand, a variety of new technologies are becoming available for patients to choose from. One of these on the forefront of entering the United States for use is the LipoSonix system.
LipoSonix reduces fat volume by focusing high-intensity ultrasound energy on the problem-area, causing no harm to the skin or surrounding tissue and organs, while disrupting fat cells. Once these have been broken down, one of the body’s debris-collection systems, macrophages, engulf the damaged adipose cells. As the fat is disposed of, patients begin to notice a marked decrease in local fat volume.
The Procedure
Liposonix takes around 30 to 60 minutes for the entire abdomen and is relatively painless and relaxing. Occasionally patients feel cold, heat, tingling, or slight discomfort.
After Treatment
There is no recovery period after LipoSonix and patients can resume their normal routine immediately afterward. Side effects are temporary and include redness, mild bruising, tenderness, hematomas, and minor swelling. Results generally appear within 3 months after the first treatment session, but many patients notice changes even sooner. The results are permanent when combined with an ongoing diet and exercise regiment. However, additional treatments or maintenance therapy after six months is also available.
Am I a good candidate?
LipoSonix is generally intended for:
- Stomach
- Thighs
- Love Handles
- Back
- Bra line fat
- Hips
- Buttocks
- Any other problem areas resistant to diet and exercise.
Most people are good candidates for LipoSonix, with few exceptions, such as those who are pregnant, those using certain hematologic medications, those with BMI greater than 30 (obese), cancer, or those with less than 1cm of fatty tissue below ideal treatment depth.
It is important to remember that LipoSonix and similar procedures are not treatments for obesity or a weight loss cure. They are intended for body sculpting and minor volume depletion only.
Safety
LipoSonix will enter the US market pending FDA approval with eight years and $50 million dollars in research behind it. Over 100 clinical studies demonstrate its safety and proven results, using CT scanning, MRI, blood panels, and ultrasound to analyze effectiveness on the cellular level and through abdomen measurement.



